Bone Heath Improved By Everolimus Plus Exemestane In Post-Menopausal Women With Advan

[News]

Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone...

More... (http://www.medicalnewstoday.com/releases/243340.php)